These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 9600204

  • 1. Molecular genetic correlates of p16, cdk4, and pRb immunohistochemistry in glioblastomas.
    Burns KL, Ueki K, Jhung SL, Koh J, Louis DN.
    J Neuropathol Exp Neurol; 1998 Feb; 57(2):122-30. PubMed ID: 9600204
    [Abstract] [Full Text] [Related]

  • 2. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
    Nielsen GP, Burns KL, Rosenberg AE, Louis DN.
    Am J Pathol; 1998 Jul; 153(1):159-63. PubMed ID: 9665476
    [Abstract] [Full Text] [Related]

  • 3. Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene.
    Ichimura K, Schmidt EE, Goike HM, Collins VP.
    Oncogene; 1996 Sep 05; 13(5):1065-72. PubMed ID: 8806696
    [Abstract] [Full Text] [Related]

  • 4. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma.
    Sonoda Y, Yoshimoto T, Sekiya T.
    Oncogene; 1995 Nov 16; 11(10):2145-9. PubMed ID: 7478535
    [Abstract] [Full Text] [Related]

  • 5. [The expression of p16, CDK4 and pRb in hepatocellular carcinomas].
    Luo D, Liu Q, Su J.
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun 16; 7(2):94-5. PubMed ID: 10488417
    [Abstract] [Full Text] [Related]

  • 6. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
    Ueki K, Ono Y, Henson JW, Efird JT, von Deimling A, Louis DN.
    Cancer Res; 1996 Jan 01; 56(1):150-3. PubMed ID: 8548755
    [Abstract] [Full Text] [Related]

  • 7. p14ARF deletion and methylation in genetic pathways to glioblastomas.
    Nakamura M, Watanabe T, Klangby U, Asker C, Wiman K, Yonekawa Y, Kleihues P, Ohgaki H.
    Brain Pathol; 2001 Apr 01; 11(2):159-68. PubMed ID: 11303791
    [Abstract] [Full Text] [Related]

  • 8. Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.
    Maelandsmo GM, Flørenes VA, Hovig E, Oyjord T, Engebraaten O, Holm R, Børresen AL, Fodstad O.
    Br J Cancer; 1996 Apr 01; 73(8):909-16. PubMed ID: 8611425
    [Abstract] [Full Text] [Related]

  • 9. Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas.
    Biernat W, Tohma Y, Yonekawa Y, Kleihues P, Ohgaki H.
    Acta Neuropathol; 1997 Oct 01; 94(4):303-9. PubMed ID: 9341929
    [Abstract] [Full Text] [Related]

  • 10. Expression of the cell-cycle regulatory proteins (pRb, cyclin D1, p16INK4A and cdk4) in human endometrial cancer: correlation with clinicopathological features.
    Semczuk A, Miturski R, Skomra D, Jakowicki JA.
    Arch Gynecol Obstet; 2004 Jan 01; 269(2):104-10. PubMed ID: 14648178
    [Abstract] [Full Text] [Related]

  • 11. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
    Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J, Bartek J.
    Cancer Res; 1996 Dec 01; 56(23):5475-83. PubMed ID: 8968104
    [Abstract] [Full Text] [Related]

  • 12. Alteration of pRb/p16/cdk4 regulation in human osteosarcoma.
    Benassi MS, Molendini L, Gamberi G, Ragazzini P, Sollazzo MR, Merli M, Asp J, Magagnoli G, Balladelli A, Bertoni F, Picci P.
    Int J Cancer; 1999 Oct 22; 84(5):489-93. PubMed ID: 10502725
    [Abstract] [Full Text] [Related]

  • 13. Genetic profile of gliosarcomas.
    Reis RM, Könü-Lebleblicioglu D, Lopes JM, Kleihues P, Ohgaki H.
    Am J Pathol; 2000 Feb 22; 156(2):425-32. PubMed ID: 10666371
    [Abstract] [Full Text] [Related]

  • 14. Analysis of cell cycle regulators: p16INK4A, pRb, and CDK4 in low- and high-grade meningiomas.
    Tse JY, Ng HK, Lo KW, Chong EY, Lam PY, Ng EK, Poon WS, Huang DP.
    Hum Pathol; 1998 Nov 22; 29(11):1200-7. PubMed ID: 9824096
    [Abstract] [Full Text] [Related]

  • 15. Mutations of TP53, amplification of EGFR, MDM2 and CDK4, and deletions of CDKN2A in malignant astrocytomas.
    Biernat W, Debiec-Rychter M, Liberski PP.
    Pol J Pathol; 1998 Nov 22; 49(4):267-71. PubMed ID: 10323080
    [Abstract] [Full Text] [Related]

  • 16. CDK4 gene amplification in osteosarcoma: reciprocal relationship with INK4A gene alterations and mapping of 12q13 amplicons.
    Wei G, Lonardo F, Ueda T, Kim T, Huvos AG, Healey JH, Ladanyi M.
    Int J Cancer; 1999 Jan 18; 80(2):199-204. PubMed ID: 9935200
    [Abstract] [Full Text] [Related]

  • 17. Alterations in the regulatory pathway involving p16, pRb and cdk4 in human chondrosarcoma.
    Asp J, Inerot S, Block JA, Lindahl A.
    J Orthop Res; 2001 Jan 18; 19(1):149-54. PubMed ID: 11332612
    [Abstract] [Full Text] [Related]

  • 18. Alterations of p16-pRb pathway and chromosome locus 9p21-22 in sporadic invasive breast carcinomas.
    Gorgoulis VG, Koutroumbi EN, Kotsinas A, Zacharatos P, Markopoulos C, Giannikos L, Kyriakou V, Voulgaris Z, Gogas I, Kittas C.
    Mol Med; 1998 Dec 18; 4(12):807-22. PubMed ID: 9990866
    [Abstract] [Full Text] [Related]

  • 19. Expression of the RB protein, allelic imbalance of the RB gene and amplification of the CDK4 gene in metaplasias, dysplasias and carcinomas in Barrett's oesophagus.
    Sarbia M, Tekin U, Zeriouh M, Donner A, Gabbert HE.
    Anticancer Res; 2001 Dec 18; 21(1A):387-92. PubMed ID: 11299766
    [Abstract] [Full Text] [Related]

  • 20. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
    Dreyling MH, Bullinger L, Ott G, Stilgenbauer S, Müller-Hermelink HK, Bentz M, Hiddemann W, Döhner H.
    Cancer Res; 1997 Oct 15; 57(20):4608-14. PubMed ID: 9377576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.